Australia markets close in 5 hours 46 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4495+0.0012 (+0.27%)
At close: 04:00PM EDT
0.4376 -0.01 (-2.65%)
After hours: 06:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.74M
Enterprise value -962.02k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.34
Price/book (mrq)1.07
Enterprise value/revenue 1.30
Enterprise value/EBITDA -0.36

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 3-73.80%
S&P500 52-week change 326.94%
52-week high 31.9600
52-week low 30.4000
50-day moving average 30.5106
200-day moving average 30.9091

Share statistics

Avg vol (3-month) 334.6k
Avg vol (10-day) 353.86k
Shares outstanding 58.6M
Implied shares outstanding 68.6M
Float 84.38M
% held by insiders 19.65%
% held by institutions 134.70%
Shares short (30 Apr 2024) 438.42k
Short ratio (30 Apr 2024) 41.74
Short % of float (30 Apr 2024) 40.46%
Short % of shares outstanding (30 Apr 2024) 40.45%
Shares short (prior month 28 Mar 2024) 453.37k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 323 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -150.41%
Operating margin (ttm)-112.64%

Management effectiveness

Return on assets (ttm)-49.09%
Return on equity (ttm)-1,035.44%

Income statement

Revenue (ttm)5.18M
Revenue per share (ttm)1.55
Quarterly revenue growth (yoy)110.50%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-7.79M
Diluted EPS (ttm)-1.8300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.74M
Total cash per share (mrq)0.56
Total debt (mrq)5M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.25
Book value per share (mrq)-0.77

Cash flow statement

Operating cash flow (ttm)-4.98M
Levered free cash flow (ttm)-2.53M